MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

ZBH · NYSE

Zimmer Biomet Holdings, Inc.

Health Care · Industrial Specialties

Reference price$95.75As of Jul 28, 2026
Market capitalization$18.52B
52-week range$79.12–$108.29
S&P 500 portfolio weight0.03%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$83.00-13.3% vs. reference
Average$98.60+3.0% vs. reference
High$115.00+20.1% vs. reference
6 Buy10 Hold1 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 5, 2026Jun 2026
Consensus EPS$2.018 estimates
Expected range$1.99–$2.03Low to high EPS
Dec 2026$8.48Street EPS consensus
Dec 2027$8.92Street EPS consensus
Dec 2028$9.37Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+7.2% YoY$8.23B$7.68B
Operating income$1.1B$1.29B
Net income$0.71B$0.9B
Operating cash flow$1.7B$1.5B
Capital expenditures($0.53B)($0.44B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

BNK Invest

Zimmer Biomet Holdings Breaks Above 200-Day Moving Average - Bullish for ZBH

Zacks

ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?

Zacks

How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion?

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.